TLR4 and inflammatory bowel disease: Furthermore, SCFAs act as histone deacetylase (HDAC) inhibitors, suppressing TLR4 expression, enhancing the differentiation of regulatory T cells (Tregs), and inducing the secretion of anti-inflammatory cytokines such as IL-10, which are essential for mitigating intestinal inflammation in IBD [53].